Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse

[1]  M. Atkinson,et al.  Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy , 1990, Diabetes.

[2]  H. Binz,et al.  Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Bedossa,et al.  Syngeneic t cell transfer of diabetes into nod newborn mice: in situ studies of the autoimmune steps leading to insulin‐producing cell destruction , 1989, European journal of immunology.

[4]  N. Simpson,et al.  A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[5]  P. Chatelain,et al.  Islet cell and insulin autoantibodies in subjects at high risk for development of Type 1 (insulin-dependent) diabetes mellitus: the Lyon family study , 1988, Diabetologia.

[6]  E. Leiter,et al.  Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. , 1988, Journal of immunology.

[7]  J. Rygaard,et al.  Antigen expression of the pancreatic beta‐cells is dependent on their functional state, as shown by a specific, BB rat monoclonal autoantibody IC2 , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[8]  J. Levy,et al.  Nutrition and autoimmunity: a review. , 1986, Clinical and experimental immunology.

[9]  L. Wicker,et al.  Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice , 1986, Diabetes.

[10]  G. Karsenty,et al.  CYCLOSPORIN INCREASES THE RATE AND LENGTH OF REMISSIONS IN INSULIN-DEPENDENT DIABETES OF RECENT ONSET Results of a Multicentre Double-blind Trial , 1986, The Lancet.

[11]  P. Hunt,et al.  Suppressive effects of insulin and insulin-like growth factor-1 (IGF1) on immune responses. , 1986, Journal of immunology.

[12]  G. Eisenbarth Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .

[13]  M. Nishida,et al.  New Diabetogenic Streptozocin Analogue, 3-O-Methyl-2-{[(methylnitrosoamino) carbonyl]amino}-D-glucopyranose: Evidence for a Glucose Recognition Site on Pancreatic B-Cells , 1986, Diabetes.

[14]  K. Buschard,et al.  Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals , 1985, Diabetologia.

[15]  M. Marcelli,et al.  Influence of a transplantable insulinoma on the pancreatic status of insulin and pancreatic polypeptide in the rat , 1985, Diabetologia.

[16]  K. A. Wall,et al.  Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.

[17]  J. McNally,et al.  EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.

[18]  J. Helderman Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte. , 1981, The Journal of clinical investigation.

[19]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[20]  L. Herzenberg,et al.  Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens * , 1979, Immunological reviews.

[21]  J. Mirouze,et al.  Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas , 1978, Diabetologia.

[22]  P. Davoren The isolation of insulin from a single cat pancreas. , 1962, Biochimica et biophysica acta.

[23]  G. Bottazzo,et al.  Islet-cell and insulin autoantibodies in diabetes , 1987 .